DED Research Roundup
Episode description
Welcome to "Try Not 2 Blink," where cutting-edge research meets practical clinical insights! In today's episode, Roya and Sheila delve into a compelling headline: "Scleral lenses are effective and ‘safe overall’ for pediatric patients." They will dissect a groundbreaking retrospective study, exploring key findings such as the alarming fact that ocular surface disease accounted for 70% of cases, and why clinicians should be proactive in referring young patients for scleral lens assessments.
We are privileged to welcome Dr. Sathi Maiti, a prominent figure in dry eye research, who has been instrumental in many recent pivotal studies. Dr. Maiti will share her expertise on Xdemvy, the innovative treatment for Demodex blepharitis, and provide best practices for its application in clinical settings.
Additionally, we’ll tackle the ongoing debate surrounding Meibo—whether it’s classified as a lubricating drop or a drug—and review the latest advancements in in-office dry eye treatments. We’ll also address how to identify and manage ocular pain disorders, including neuropathic and neurotrophic pain.
This is an episode you won't want to miss!
Do you have a specific topic you’re passionate about? Or perhaps an expert or prominent figure you’d like us to feature on our podcast? We invite you to share your suggestions and help shape our future content!
Don’t hesitate to reach out to us at [email protected]
SOURCES
Scleral Lenses are Safe for Kids
21 Year Retrospective Review: Kids + Scleral Lenses
Dr. Sathi Maiti: Periman Eye Institute
CIC clinical investigator AAO
2020 on sight
Try Not to Blink Podcast is powered by Valley Contax